Krka, d. d.
KRK
Rank in Stocks
#2156
Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved... Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved in the research, production, promotion, and sale of various pharmaceutical goods. Its market presence spans Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and numerous other international territories. The company's offerings are categorized into prescription medications, over-the-counter products, and veterinary health solutions. Its prescription drug pipeline targets a broad spectrum of medical conditions, including cardiovascular disorders, gastrointestinal issues, central nervous system ailments, pain management, anti-infective treatments, conditions affecting blood and blood-forming organs, urological problems, diabetes, and oncology. The array of non-prescription items includes products for oral and throat care, cough and cold remedies, analgesics, nasal preparations, vitamin and mineral supplements, products designed to enhance cerebral and peripheral circulation, digestive aids, and various general healthcare products. Furthermore, Krka supplies animal health products such as anti-infectives, antiparasitics, and other specialized formulations for both livestock and companion animals. Beyond its pharmaceutical operations, the company also provides health resort and tourist services. Krka, d. d. was established in 1954 and has its corporate headquarters in Novo Mesto, Slovenia.
Share Price
$313.05
Last synced: 2026-10-19
Market Cap
$9.48B
Change (1 day)
-1.77%
Change (1 year)
30.64%
Country
SI
Trade Krka, d. d. (KRK)
Category
Healthcare
Earnings for Krka, d. d. (KRK)
Earnings in Jun 2026 TTM: $613.56M
According to Krka, d. d. latest financial reports the company's current earnings are $613.56M. In 2023 the company made an earning of $405.84M, a decrease compared to its 2022 earnings that were of $464.55M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Krka, d. d. from 2010 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $613.56M | 40.70% |
| 2024 | $436.08M | 7.45% |
| 2023 | $405.84M | -12.64% |
| 2022 | $464.55M | 12.72% |
| 2021 | $412.12M | -0.18% |
| 2020 | $412.85M | 29.40% |
| 2019 | $319.06M | 37.06% |
| 2018 | $232.79M | 10.12% |
| 2017 | $211.39M | 72.75% |
| 2016 | $122.37M | -37.64% |
| 2015 | $196.22M | -7.49% |
| 2014 | $212.12M | -23.39% |
| 2013 | $276.88M | 10.18% |
| 2012 | $251.29M | -2.93% |
| 2011 | $258.87M | -8.40% |
| 2010 | $282.60M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 187.59% |
IN
|
